STRATA Skin Sciences to Present at Fall Harvest – Best Ideas from the Buy Side on Wednesday October 6, 2021

0

Receive instant alerts for news on your actions. Claim your 1-week free trial for StreetInsider Premium here.


HORSHAM, Pa., September 29, 2021 (GLOBE NEWSWIRE) – STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to the development, commercialization and commercialization of innovative products for the treatment of skin conditions , today announced that the company has been invited to present at the Fall Harvest – Best Ideas from the Buy-Side conference. CEO, Robert J. Moccia will present at the conference.

STRATA Skin Sciences is scheduled to present on Wednesday, October 6 at 11:00 a.m. EST. Management will be available for one-on-one meetings to be held throughout the conference. Interested parties can access a live, archived webcast of the presentation in the investor section of the Company’s website at www.strataskinsciences.com.

To receive additional information, request an invitation, or schedule a one-on-one meeting, please email [email protected]

Investors can register here.

About the MicroCap Rodeo Best Ideas conferenceThe MicroCap Rodeo is back with its “Best Ideas” conference. This conference is a virtual conference that introduces you to the 35 best ideas from the buy side. Qualified institutional investors recommended each of the 35 companies featured as one of their best ideas.

About STRATA Skin Sciences, Inc.STRATA Skin Sciences is a dermatology medical technology company dedicated to the development, commercialization and commercialization of innovative products for the treatment of dermatological conditions. Its products include XTRAC® and now Pharos® excimer lasers and VTRAC® lamp systems used in the treatment of psoriasis, vitiligo and various other skin conditions.

The company’s proprietary XTRAC and newly acquired Pharos excimer lasers deliver a highly targeted therapeutic beam of UVB light to treat psoriasis, vitiligo, eczema, atopic dermatitis and leukoderma, diseases that affect more than 31 million patients in the United States alone.

STRATA’s unique business model leverages Direct-to-Consumer (DTC) targeted advertising to generate awareness and uses its in-house call center and insurance advocacy teams to increase the volume of the Company’s partner dermatology clinics.

Investor contacts:

Main logo

Source: STRATA Skin Sciences, Inc.


Source link

Leave A Reply

Your email address will not be published.